Cargando…

Vitamin D status in ANCA-associated vasculitis

OBJECTIVE: Vitamin D might participate in the pathogenesis of several immune-mediated diseases, but few related data are available for ANCA-associated vasculitis (AAV). In this study, we analysed the association between vitamin D status and disease in patients with AAV. METHODS: Serum levels of 25(O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doubelt, Irena, Cuthbertson, David, Carette, Simon, Khalidi, Nader A, Koening, Curry L, Langford, Carol, McAlear, Carol A, Moreland, Larry W, Monach, Paul, Seo, Philip, Specks, Ulrich, Warrington, Kenneth J, Merkel, Peter A, Pagnoux, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Concise Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977244/ https://www.ncbi.nlm.nih.gov/pubmed/36874269 http://dx.doi.org/10.1093/rap/rkad021

Ejemplares similares

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
por: Michailidou, Despina, et al.
Publicado: (2022)

Clinical Manifestations and Long‐Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America
por: Doubelt, Irena, et al.
Publicado: (2021)

Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative Analysis
por: Doubelt, Irena, et al.
Publicado: (2022)

Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Almaani, Salem, et al.
Publicado: (2023)

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis
por: Rhee, Rennie L., et al.
Publicado: (2018)

Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based Study
por: Krischer, Jeffrey, et al.
Publicado: (2017)

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020)

Circulating Angiopoietin-2 as a Biomarker in ANCA-Associated Vasculitis
por: Monach, Paul A., et al.
Publicado: (2012)

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
por: Smith, Rona M, et al.
Publicado: (2023)

Serum Biomarkers in Patients with Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
por: Dejaco, Christian, et al.
Publicado: (2015)

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Merkel, Peter A., et al.
Publicado: (2017)

Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA‐Associated Vasculitis
por: Monach, Paul A., et al.
Publicado: (2021)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
por: Thompson, Gwen E., et al.
Publicado: (2020)

Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone
por: Micheletti, Robert G., et al.
Publicado: (2020)

Risk factors for serious infections in ANCA-associated vasculitis
por: Odler, Balazs, et al.
Publicado: (2023)

Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial
por: Gopaluni, Seerapani, et al.
Publicado: (2017)

Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism
por: Casal Moura, Marta, et al.
Publicado: (2023)

Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis
por: Conklin, Laurie S., et al.
Publicado: (2018)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
por: Robson, Joanna C, et al.
Publicado: (2018)

Circulating autoreactive proteinase 3(+) B cells and tolerance checkpoints in ANCA-associated vasculitis
por: Berti, Alvise, et al.
Publicado: (2021)

Diagnostic delays in vasculitis and factors associated with time to diagnosis
por: Sreih, Antoine G., et al.
Publicado: (2021)

Update in the Management of ANCA-Associated Vasculitis: Recent Developments and Future Perspectives
por: Samman, Karla N., et al.
Publicado: (2021)

Proteomic profile of uninvolved versus crescentic glomeruli in MPO-ANCA-associated vasculitis
por: Sethi, Amit, et al.
Publicado: (2023)

Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
por: Merkel, Peter A., et al.
Publicado: (2021)

ANCA Associated Vasculitis Subtypes: Response [Letter]
por: Merkel, Peter A, et al.
Publicado: (2022)

Pustular Vasculitis: Different Names for Same Entity?
por: Kaushik, Shivani B., et al.
Publicado: (2019)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Hemorrhagic Varicella with Cutaneous Vasculitis and Isotopic Phenomenon
por: Pangti, Rashi, et al.
Publicado: (2021)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

Development of Canadian Recommendations for the Management of ANCA-Associated Vasculitides: Results of the National Needs Assessment Questionnaire
por: Famorca, Leilani, et al.
Publicado: (2015)

What you should know about PR3-ANCA: Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA
por: Specks, Ulrich
Publicado: (2000)

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences
por: Collister, David, et al.
Publicado: (2022)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_23naee0qqlj1v5961vdl8revtu